PrivatePulse·Companies·Devoted Health vs Benchling

Devoted Health vs Benchling: employee equity compared

Secondary market prices, valuation trajectory, equity structure, and liquidity outlook for employees choosing between Devoted Health and Benchling.

Secondary market data updated monthly · Sources: Hiive, Forge

Devoted Health

Healthcare · United States · Founded 2017

Technology-enabled Medicare Advantage insurer combining owned primary care clinics with proprietary data analytics to improve outcomes for seniors.

Last primary round$12.6B · Series C (2021-06)
Secondary market$13B (+3% vs primary)
Annual revenue$1.5B ARR · +40% YoY (solid)
Headcount~2,000
Equity typeISO/NSO
Strike price range$25–$40 (depends on cohort)
Illiquidity discount~25%
Last round leadAndreessen Horowitz
Liquidity outlook

IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.

Key equity angle

Healthcare tech with long sales cycles; ISO/NSO options; regulatory milestones drive value

↑ Higher secondary premium

Benchling

Healthcare · United States · Founded 2012

Life science R&D platform combining electronic lab notebook, molecular biology tools, and LIMS (lab information management) for biopharma, biotech, and agricultural science.

Last primary round$6.1B · Series E (2021-01)
Secondary market$6.3B (+3% vs primary)
Annual revenue$0.1B ARR · +30% YoY (solid)
Headcount~700
Equity typeISO/NSO
Strike price range$18–$30 (depends on cohort)
Illiquidity discount~25%
Last round leadCoatue Management
Liquidity outlook

No near-term IPO expected. Company likely 2028+ at earliest; patient equity required.

Key equity angle

Healthcare tech with long sales cycles; ISO/NSO options; regulatory milestones drive value

Key differences for employees

Equity structure

Devoted Health grants ISO/NSO with strike prices ranging from $25–$40 depending on your grant year. Benchling grants ISO/NSO with strike prices from $18–$30.

Secondary market premium

The secondary market is pricing Devoted Health at a +3% premium over its last primary round ($12.6B$13B). Benchling trades at +3% over its last round ($6.1B$6.3B). A higher secondary premium signals stronger investor demand and potentially better near-term liquidity for employees looking to sell.

Revenue and growth

Devoted Health runs at $1.5B ARR, growing +40% YoY (solid). Benchling runs at $0.1B ARR, growing +30% YoY (solid). Revenue growth rate matters for equity because it drives the peer-multiple valuation — the method most correlated with exit multiples.

Liquidity timeline

Devoted Health: IPO plausible 2027–2029 if growth trajectory holds. Liquidity may come via tender offer or strategic acquisition before listing.

Benchling: No near-term IPO expected. Company likely 2028+ at earliest; patient equity required.

Calculate your specific grant

Enter your actual shares, equity type, and strike price. PrivatePulse calculates your personal equity value at both companies using 4 independent methods.

Frequently asked questions

Is Devoted Health or Benchling a better company to work at for equity?
There's no universal answer — it depends on your risk profile, time horizon, and specific grant terms. Devoted Health at $12.6B and Benchling at $6.1B offer very different risk/reward profiles. Use the calculator above to model your exact grant at each company.
How do I know if my Devoted Health or Benchling equity is fairly priced?
Compare your grant's implied per-share value against the secondary market price. If investors are paying a premium on Hiive or Forge over the last primary round, that's a signal of strong demand. PrivatePulse shows you the gap between your 409A and what the secondary market says.
Can I sell my Devoted Health or Benchling shares on the secondary market?
Secondary market transactions (Hiive, Forge, Caplight) require accredited investor status and your company's consent — most private companies have right-of-first-refusal (ROFR) provisions. Tender offers, when available, are typically the most accessible path to partial liquidity for employees.

More equity comparisons